Iris Verel Selected Research

(124)I-cMAb U36

12/2004	High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.
10/2003	Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
8/2003	89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
8/2003	Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iris Verel Research Topics

Disease

7	Neoplasms (Cancer) 01/2016 - 05/2002
4	Head and Neck Neoplasms (Head and Neck Cancer) 12/2004 - 05/2002
2	Squamous Cell Carcinoma of Head and Neck 08/2003 - 05/2002
1	Disease Progression 01/2016
1	Breast Neoplasms (Breast Cancer) 06/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2004

Drug/Important Bio-Agent (IBA)

4	(124)I-cMAb U36IBA 12/2004 - 08/2003
3	Monoclonal AntibodiesIBA 04/2004 - 05/2002
2	AntibodiesIBA 01/2016 - 05/2002
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2003 - 08/2003
2	AntigensIBA 10/2003 - 05/2002
1	Galectin 1 (LGALS1)IBA 01/2016
1	Galectins (Galectin)IBA 01/2016
1	FibrinIBA 06/2015
1	N-succinyldesferrioxamine BIBA 10/2003
1	AcidsIBA 10/2003
1	Immunoconjugates (Immunoconjugate)IBA 08/2003
1	Hepatitis B e AntigensIBA 05/2002
1	EpitopesIBA 05/2002

Therapy/Procedure

3	Radioimmunotherapy 01/2005 - 08/2003